Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
+2.38M
-
Total reported value, excl. options
-
$1.25B
-
Value change
-
+$183M
-
Put/Call ratio
-
0.39
-
Number of buys
-
112
-
Number of sells
-
-60
-
Price
-
$81.76
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q2 2015
207 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2015.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 207M outstanding shares and own 7.38% of the company stock.
Largest 10 shareholders include FMR LLC (2.21M shares), Pentwater Capital Management LP (1.52M shares), Viking Global Investors LP (1.4M shares), GILDER GAGNON HOWE & CO LLC (820K shares), Visium Asset Management, LP (791K shares), VANGUARD GROUP INC (708K shares), WASATCH ADVISORS INC (703K shares), COLUMBUS CIRCLE INVESTORS (541K shares), STATE STREET CORP (522K shares), and Polar Capital LLP (323K shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.